Here, we review and summarize evidence that dysregulation of sphingolipid metabolism, in particular, ceramide, C1P, S1P, acid sphingomyelinase, and SM, correlates with the pathogenesis of bone disease, osteoporosis, and dysfunction due to bacterial infection. The gene discussed is MBTPS1; the disease is osteoporosis.